Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept versus tacrolimus immune monitoring study in kidney transplant recipients
NL-OMON28288Recruiting
- Sponsor
- Erasmus MC
- Start
- Oct 2013
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial in kidney transplant comparing Belatacept with Tacrolimus standard therapy (2 arms). Primary endpoints: Presence, frequency, and characteristics of effector CD4+ and CD8+ T cells, T-B-cell interaction during costimulation blockade and 1 more. Started Oct 2013; status: recruiting.
02
Drugs
belatacepttacrolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NL-OMON28288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28288.